Literature DB >> 7791094

delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.

K L McCoy1, D Gainey, G A Cabral.   

Abstract

delta 9-Tetrahydrocannabinol (THC) exposure suppresses multiple immunological functions of macrophages. The ability of macrophages exposed to THC to process and present soluble protein antigens was investigated by the stimulation of antigen-specific helper T cell hybridomas to secrete interleukin-2. The T cell response to hen egg lysozyme was dramatically reduced after a 24-hr pretreatment of a macrophage hybridoma with THC. In contrast, THC exposure did not alter the capacity of the macrophage hybridoma to process chicken ovalbumin and augmented their presenting cell function for a pigeon cytochrome c response. These findings could not be attributed to differential effects of THC on either cell viability or expression of the antigen receptor-associated CD3 complex by the T cells. The level of T cell activation with peptides of lysozyme and cytochrome c, which do not require processing, was inhibited only at the highest concentrations of THC, suggesting that THC mainly affects antigen processing. Peritoneal macrophages exposed to THC during an antigen pulse and fixed with paraformaldehyde showed similar effects on the subsequent T cell responses to lysozyme and cytochrome c in the absence of THC, arguing against a possible influence of THC on the T cells. Therefore, THC differentially modulates the capacity of macrophages to process antigens that is necessary for the activation of CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791094

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice.

Authors:  G Kunos; S Bátkai
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

3.  Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity.

Authors:  Der-zen LIU; Chieh-min HU; Chung-hsiung HUANG; Shiaw-pyng WEY; Tong-rong JAN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

Review 4.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

5.  Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection.

Authors:  Peer W F Karmaus; Weimin Chen; Robert B Crawford; Jack R Harkema; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2011-08-26       Impact factor: 4.962

6.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Authors:  A M Malfait; R Gallily; P F Sumariwalla; A S Malik; E Andreakos; R Mechoulam; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 7.  Marijuana. Respiratory tract effects.

Authors:  B E Van Hoozen; C E Cross
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

8.  Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Authors:  Marylou V Solbrig; Neal Hermanowicz
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

Review 9.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

Review 10.  Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Authors:  Sadiye Amcaoglu Rieder; Ashok Chauhan; Ugra Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Immunobiology       Date:  2009-05-20       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.